Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Changing concepts of hormone receptor-positive advanced breast cancer therapy.

× No keyword cloud information.

10 in total

1. Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.

Authors: Claire C Conley; McKenzie McIntyre; Nicole A Pensak; Filipa Lynce; Deena Graham; Roohi Ismail-Khan; Katherine Lopez; Susan T Vadaparampil; Suzanne C O'Neill
Journal: Breast Cancer Res Treat Date: 2022-01-07 Impact factor: 4.872

2. Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.

Authors: Daniella Klebaner; Stephen Hamilton-Dutoit; Thomas Ahern; Anatasha Crawford; Thomas Jakobsen; Deirdre P Cronin-Fenton; Per Damkier; Emiel Janssen; Anders Kjaersgaard; Anne Gulbech Ording; Håvard Søiland; Henrik Toft Sørensen; Timothy L Lash; Ylva Hellberg
Journal: PLoS One Date: 2017-03-16 Impact factor: 3.240

3. Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2- Advanced Breast Cancer.

Authors: Ning Xie; Tao Qin; Wei Ren; Herui Yao; Yunfang Yu; Huangming Hong
Journal: Cancer Manag Res Date: 2020-06-04 Impact factor: 3.989

4. Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.

Authors: Jiangping Yang; Jiaqi Han; Maolang Tian; Kun Tian; Wenjun Liao; Xi Yan
Journal: Cancer Manag Res Date: 2020-12-15 Impact factor: 3.989

5. Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients.

Authors: Vinodh Kumar Radhakrishnan; Lorraine Christine Hernandez; Kendra Anderson; Qianwei Tan; Marino De León; Daisy D De León
Journal: Int J Endocrinol Date: 2015-09-10 Impact factor: 3.257

Review 6. Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer.

Authors: Denise A Yardley
Journal: Breast Cancer (Dove Med Press) Date: 2016-05-03

Review 7. Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Authors: Adam M Brufsky
Journal: Clin Med Insights Oncol Date: 2015-12-30

Review 8. Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.

Authors: William J Gradishar
Journal: Cancer Manag Res Date: 2016-07-11 Impact factor: 3.989

9. Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study.

Authors: Norikazu Masuda; Reiki Nishimura; Masato Takahashi; Kenichi Inoue; Shinji Ohno; Hiroji Iwata; Yuko Mori; Satoshi Hashigaki; Yasuaki Muramatsu; Takashi Nagasawa; Yoshiko Umeyama; Masakazu Toi
Journal: Cancer Sci Date: 2018-02-22 Impact factor: 6.716

10. Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib.

Authors: Jin Hyun Park; Hyunkyung Park; Ki Hwan Kim; Jin-Soo Kim; In Sil Choi; Eun Youn Roh; Ji Eun Kim; Mee Soo Chang
Journal: J Breast Cancer Date: 2019-11-13 Impact factor: 3.588

10 in total